COL1A1 and Hepatic fibrosis: Results from LX-2 cells demonstrated that β-sitosterol decreased the protein expression of COL1A1 when compared to the control, indicating its capacity to ameliorate liver fibrosis in both in vivo and in vitro conditions (Figure 5A).